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Extent of resection needed to treat lung cancer has long been an issue. The sole randomised controlled trial, reported by the Lung
Cancer Study Group, advised against limited resection as standard surgery even for small peripheral non-small-cell lung cancers
(p3cm), because of frequent local recurrences. Elsewhere, conflicting results have been reported from different institutions. We
therefore conducted a meta-analysis of reported studies to compare survival of stage I patients between limited resection and
standard lobectomy. A MEDLINE web search for computer-archived bibliographic data yielded 14 articles suitable for analysis.
Combined survival differences (survival rate with lobectomy minus that with limited resection) at 1, 3, and 5 years after resection
according to the DerSimonian–Laird random effects model were 0.7% (95% CI,  0.8 to 2.1; P¼0.3659), 1.9% (95% CI,  3.7 to 7.4;
P¼0.5088), and 3.6% (95% CI,  0.4 to 10.5; P¼0.3603), respectively. None of these survival differences were significant, indicating
that survival after limited resection for stage I lung cancer was comparable to that after lobectomy. However, since interstudy
heterogeneity was detected, caution is required in interpretation of the results.
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Limited resection for lung cancer was proposed in the early 1970s
(Le Roux, 1972). Acceptable results of segmentectomy in a large
number of patients were reported by Jensik et al (1973). Since
then, several retrospective studies (Breyer and Jensik, 1985; Stair
et al, 1985; Jensik, 1987; Temeck et al, 1992) considering efficacy of
limited resection have been reported. In 1995, the Lung Cancer
Study Group (LCSG) published final results of a randomised
controlled trial (RCT) (Ginsberg and Rubinstein, 1995; Lederle,
1996) comparing local recurrence and survival after limited
resection with those after standard lobectomy for stage IA non-
small-cell lung cancer (NSCLC). Representing the only randomised
trial worldwide to address the question of whether limited
resection truly is comparable to standard lobectomy, that trial
showed frequent locoregional recurrences and a tendency toward
poorer survival in the limited resection group.
Although the randomised trial (Ginsberg and Rubinstein, 1995)
concluded that limited resection should not be standard surgery
even for small peripheral NSCLC, several surgeons (Kodama et al,
1997; Tsubota et al, 1998; Koike et al, 2003) have continued to
perform some intentional limited resections. Indeed, results
reported from various institutions up to now have been conflict-
ing. Considering recent implementation of minimally invasive
surgical techniques such as video-assisted thoracoscopic surgery
(VATS), efficacy of limited resection in small, node-negative
NSCLC needs to be re-evaluated (Sugarbaker and Strauss, 2000).
We therefore conducted a meta-analysis of published studies to
quantitatively review survival data for limited resection of lung
cancer in comparison with data for standard lobectomy.
MATERIALS AND METHODS
Eligibility criteria for meta-analysis
This meta-analysis was limited to studies comparing survival data
of limited resection with those of standard lobectomy. The
following eligibility criteria were established before collecting
articles: (1) ‘Limited resection’ was defined as sublobular resection,
including wedge resection and segmentectomy. (2) Operative
approaches could include either thoracotomy or VATS. (3)
Survival rates for a specific time interval after operation were
stated in the article. (4) Study subjects had to be limited to clinical
stage I patients. (5) Median follow-up time was to exceed 2 years.
(6) Articles were published in English in the periodical
medical literature from 1970 to August 2004. (7) When multiple
articles by the same author or study group analysed the same
series of patients, a single most informative article was chosen
for the meta-analysis.
Collection of published studies
The MEDLINE web search for computer-archived bibliographic
data concerning limited resection and postoperative survival in
lung cancer was primarily performed in August 2004. Keywords
lung ‘cancerþlimited resection’, ‘lung cancerþwedge resection’,
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s‘lung cancerþsegmentectomy’, and ‘limited resection þlobec-
tomy’ hit 627, 344, 193, and 117 citations, respectively. Manual
selection of relevant studies was carried out based on the summary
analysis. Overlapping or unrelated articles were excluded, and
items from hand-searched bibliographies were added. Of 18
articles initially found by the methods above, two were excluded
for being reported by the same author or study group analysing a
series of patients more informatively considered
in another article. In three articles, advanced disease stages
were included. One report of these three also was among the
two representing overlap. Thus, four articles (Errett et al,
1985; Pastorino et al, 1991; Sugarbaker and Strauss, 2000;
Miller et al, 2002) were excluded (Table 1), while 14 articles
fulfilled eligibility criteria.
Statistical analyses
DerSimonian–Laird random effects analysis (DerSimonian and
Laird, 1986) was used to estimate the survival difference (i.e.
survival rate after standard lobectomy minus that of limited
resection) at the end points of 1, 3, and 5 years after operation.
Generally used to combine heterogeneous studies, this method
produces a combined survival difference and a 95% confidence
interval with a heterogeneity test at each end point. Survival rates
were derived from published survival curves when not provided
explicitly in the text or tables. Subjects censored prior to each end
point were subtracted from the denominators (number of patients
for follow-up), giving a conservative confidence interval for the
summary statistic. Censored cases were counted by placing tick
marks on survival curves when provided, as described by
Mitsudomi et al (2000). The correlation coefficient (r) was
calculated to examine the relationship between two variables.
Significance was tested by the Bartlett test. For these tests, a
P-value o0.05 was considered significant.
Publication bias was tested by the method of Egger et al (1997);
for this, a P-value o0.1 was considered significant.
RESULTS
A total of 14 studies (Hoffmann and Ransdell, 1980; Read et al,
1990; Date et al, 1994; Warren and Faber, 1994; Ginsberg and
Rubinstein, 1995; Harpole et al, 1995; Lederle, 1996; Kodama et al,
1997; Landreneau et al. 1997; Pastorino et al, 1997; Kwiatkowski
et al, 1998; Okada et al, 2001; Koike et al, 2003; Campione et al,
2004; Keenan et al, 2004) served as data sources for the present
meta-analysis (Table 2). Their designs were retrospective in 12,
matched-pair in one, and RCT in one. Limited resection was
performed for a total of 903 patients, while comparable standard
lobectomy was performed for 1887 patients. Overall classification
of histologic types including additional 125 pneumonectomies
in three studies (Harpole et al, 1995; Pastorino et al, 1997;
Kwiatkowski et al, 1998) were 878 squamous cell carcinomas and
1617 nonsquamous cell carcinomas. Histologic types were not
mentioned in two studies (Landreneau et al, 1997; Keenan et al,
2004) including 420 patients. Stages and tumour–nodes–meta-
stasis (TNM) profiles of patients who underwent limited resection
were IA (T1N0M0) and IB (T2N0M0).
Table 1 Studies excluded from the present meta-analysis
Authors
Study
design Stage
No. of limited
resection
No. of
lobectomy
Reasons for
exclusion
Survival
difference
Errett et al (1985) RS IA+B
IIA 100 (W) 97 Included advanced and unknown stages NS
Unknown
Pastorino et al (1991) RS IA+B 61 (S+W) 411 Up dated by Pastorino et al (1997) NS
Sugarbaker and Strausss (2000) Review IA+B 58 (S+W) 172 Same series of patients was reported by
Kwiatkowski et al (1998)
Lobectomy better
Miller et al (2002) RS IA+IB
IIA Included advanced stages Lobectomy better
IIIA 25 (S+W) 75
p1cm
RS¼retrospective study; S¼segmentectomy; W¼wedge resection; ND¼not described; NS¼not significant.
Table 2 Studies included in the present meta-analysis
Authors
Study
design Stage
No. of limited
resection
No. of
lobectomy
Reasons for
limited resection
Survival
difference
Hoffmann and Ransdell (1980) RS IA 33 (W) 40
a Poor cardiopulmonary function and smaller lesions NS
Read et al (1990) RS IA 113 (1O7S+6W) 131 ND NS (CSS)
Date et al (1994) MPS IA 16 (6S+10W) 16 Poor pulmonary function Lobectomy better
Warren and Faber (1994) RS IA+B 66 (S) 103 Poor cardiopulmonary function and smaller lesions Lobectomy better
Harpole et al (1995) RS IA+B 75 (W) 193 Poor cardiopulmonary function and smaller lesions NS (CSS)
LCSG (1996) RCT IA 122 (82S+40W) 125 Randomisation NS
Kodama et al (1997) RS IA 46
b (W) 77 Intentional resection for small lesions NS
Landreneau et al (1997) RS IA 102 (W) 117 Poor cardiopulmonary function NS
Pastorino et al (1997) RS IA+B 53 (S+W) 367 ND NS
Kwiatkowski et al (1998) RS IA+B 58 (S+W) 186
c ND Lobectomy better
Okada et al (2001) RS IAp2cm 70 (S) 139 Intentional resection for small lesions p2cm NS
Koike et al (2003) RS IAp2cm 74 (60S+14W) 159 Intentional resection for small lesions p2cm NS
Campione et al (2004) RS IA 21 (S) 100 Poor cardiopulmonary function NS
Keenan et al (2004) RS IA+B 54 (8) 147 Poor pulmonary function NS
aTumours peripherally located.
bOnly intentional resection.
cIncluding 13 pneumonectomies. LCSG¼Lung Cancer Study Group; S¼segmentectomy; W¼wedge resection;
ND¼not described; NS¼not significant; MPS¼matched-pair study; RCT¼randomised controlled trial; RS¼retrospective study; CSS¼cancer-specific survival.
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sStudies included were considered highly heterogeneous for the
following reasons. The percentage of nonsquamous cell carcinoma
in each study ranged from 39.7% (Hoffmann and Ransdell, 1980)
to 90.5% (Koike et al, 2003). Further, the percentage of male
patients in each study ranged from 50.6% (Koike et al, 2003) to
100% (Hoffmann and Ransdell, 1980). Percentages of squamous
cell carcinoma in each study showed strong association with male
gender (Figure 1, r¼0.931, Po0.000l). The reason for limited
resection differed from study to study; the most frequent reason
was poor cardiopulmonary function in seven studies; limited
resection was intentional in four studies and was part of an
RCT design in one. The reason was not clearly mentioned in 3
studies. All of these differences might affect the respective
studies and contribute to interstudy heterogeneity in the present
meta-analysis.
Combined survival differences at 1, 3, and 5 years after resection
were 0.7, 1.9, and 3.6%, respectively (Figure 2A–C). None of these
combined survival differences were significant (see legend to
Figure 2). Heterogeneity testing indicated that studies were
heterogeneous at 3- and 5-year time points (see legend to Figure 2).
Publication bias was not detected at 1, 3, or 5 years; all P-values
40.1; 0.5402, 0.1807, and 0.3633, respectively.
DISCUSSION
The extent of lung resection most appropriate for small
cancers has been discussed for a number of decades.
Although limited resection for patients with poor cardiopulmonary
reserve is regarded reasonable, intentional limited resection
for patients expected to withstand standard lobectomy has not
been established. We therefore performed a meta-analysis to
examine published data. Some authors (Stewart and Parmar, 1993)
are considering meta-analysis based on individual patient’s data is
the best. However, we did not take that approach because
collecting all those data is hard to accomplish, and needs
exhaustive labour.
As meta-analysis originally was developed to combine the
results of RCTs (Yusuf et al, 1985), applying this methodology to
suitability of limited resection for lung cancer is problematic. Since
we could find only one RCT, we included additional 13 retro-
spective studies to obtain the summary statistics. Consequently, we
found significant variation between studies for tumour size,
distribution of histologic types, male/female ratio, reasons for
limited resection, and details of the operation. All of these
differences might contribute to interstudy heterogeneity, and
indeed the heterogeneity test detected considerable heterogeneity
between combined studies at time points 3 and 5 years after
resection.
Publication bias (Egger et al, 1997) also is a problem in meta-
analysis, but this was not detected in our present study; the
selected articles apparently were reasonably representative of the
actual average.
Combining 14 published reports, we concluded that while
survival after lobectomy was slightly better than that after limited
resection at 1, 3, and 5 years postoperatively, the differences
were not statistically significant. Since most included articles
were retrospective studies, we should interpret the present
results carefully.
We believe that the most important factor affecting results in
each study was the choice of indications for limited resection. In
this meta-analysis, the most frequent reason was poor cardiopul-
monary reserve. If so, overall survival in limited resection should
be worse than that in lobectomy, since many poor-risk patients
will die of diseases other than lung cancer. In a single-institution
study, overall 5-year survival in patients undergoing limited
resection because of such compromise (48%) was significantly
lower than that of patients undergoing intentional limited
resection (93%) (Kodama et al, 1997). However, if prognosis is
evaluated by cancer-specific survival (CSS), the survival rate
should be higher in compromised patients because expected
deaths from lung cancer might be diminished by prior deaths from
cardiopulmonary diseases. In the present study, since two studies
(Read et al, 1990; Harpole et al, 1995) evaluated CSS after
operation, good prognosis after limited resection might have
been overevaluated. In most studies, limited resection was
performed for smaller nodules than those resected by lobectomy,
which in itself would favour better survival in the limited resection
group, since the postoperative prognosis with IA disease is better
than with IB. Specifications of operative procedures also are
important. In intentional segmentectomy studies (Okada et al,
2001; Koike et al, 2003), nodal metastases were carefully sought
during the operation, and cases with these were strictly excluded
from limited resection. This procedure would yield a different
limited resection group from that obtained by simple wedge
resection without intraoperative nodal examination. Of 89 patients
(tumour p2cm) scheduled for limited resection in an inten-
tional study (Okada et al, 2001), 19 patients (21.3%) had to
undergo different procedures because nodal involvement was
found in 12 and local invasion was found in seven. A relatively
high frequency of lymph node metastases from small lung cancers
strongly suggests that tumour size alone is not a good criterion
for limited resection.
Histologic type of the tumour also may affect results of limited
resection. In our study (Nakamura et al, 2004), analyzsng 100
patients who underwent limited resection without systematic
lymph node dissection, the overall 5-year survival rate for 73
patients with small adenocarcinomas (p2cm) was 93.7%, which
was significantly better than for those with larger adenocarcinomas
(24.8%). In addition, we found the overall 5-year survival rate for
patients with well-differentiated adenocarcinoma (81.2%) to be
significantly better than for a group combining moderately and
poorly differentiated adenocarcinomas (30.7%). Thus, in addition
to tumour size, biologic characteristics importantly affect survival
after limited resection. Since the most reliable results are likely to
be those of the RCT, we believe that limited resection truly is
inferior to lobectomy in terms of locoregional recurrence and
survival in a study where eligibility for randomisation depends
solely on tumour size (p3o rp2cm). However, we also would
maintain that a subset of NSCLC can be resected completely by
limited resection. One example would be a small, slowly growing,
localised bronchioloalveolar carcinoma showing only ground-glass
opacity (GGO) on computed tomography (Kaneko et al, 1996; Sone
et al, 1998). In our opinion, these lesions can be resected
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Figure 1 A strong correlation is evident between percentages of
squamous cell carcinoma in the various studies and those of male patients
(r¼0.931, Po0.0001).
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scompletely by VATS wedge resection (Watanabe et al, 2002;
Nakamura et al, 2004), given their low invasiveness and absence of
lymph node metastases (Nakata et al, 2002).
In conclusion, the present meta-analysis of published data
disclosed that survival after limited resection for stage I lung
cancer is comparable to lobectomy. However, considerable
heterogeneity among studies suggests that clinicopathologic
features of patients who underwent limited resection in the studies
analysed were quite different. We believe that some lung cancers
can be cured by limited resection, if we can identify tumours of
minimally invasive nature, such as small bronchioloalveolar
carcinomas diagnosed by CT (Nakamura et al, 2004). Further
clinicopathologic studies of the biologic nature of various lung
cancers should help to address this problem.
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